pyrroles has been researched along with Seizures in 39 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (15.38) | 18.7374 |
1990's | 14 (35.90) | 18.2507 |
2000's | 8 (20.51) | 29.6817 |
2010's | 10 (25.64) | 24.3611 |
2020's | 1 (2.56) | 2.80 |
Authors | Studies |
---|---|
Aiba, M; Ito, S; Nagai, J; Tateno, T; Tsutsumi, Y | 1 |
Chońska, J; Dawidowski, M; Mika, W; Turło, J | 1 |
Agarwal, NB; Raisuddin, S; Sehar, N; Vohora, D | 1 |
Cotrina, ML; Gu, S; He, X; Huang, JH; Liu, W; Nedergaard, M; Shapiro, LA; Wang, EW; Wang, F; Wang, W; Wang, X | 1 |
Lee, JK; Singh, AK; Singh, I; Won, JS | 1 |
Hill, KL; Lipson, AC; Sheehan, JM | 1 |
Boeck, CR; Carqueja, CL; Dal'agnolo, D; de Araújo Herculano, B; Martins, WC; Piermartiri, TC; Stroeh, E; Tasca, CI; Vandresen-Filho, S | 1 |
Akgün-Dar, K; Aksu, U; Uzüm, G | 1 |
Sun, RP; Yang, L; Yin, P; Zhou, HY | 1 |
Aronica, E; Gorter, JA; Holtman, L; Schmitz, LJ; van Vliet, EA; Wadman, WJ | 1 |
de Mello, CF; de Oliveira, CV; Ferreira, J; Funck, VR; Furian, AF; Guerra, GP; Mallmann, CA; Oliveira, MS; Pereira, LM; Rambo, LM; Ribeiro, LR; Royes, LF | 1 |
Czuczwar, SJ; Luszczki, JJ; Stepien, KM; Tomaszewski, M | 1 |
Dehpour, AR; Fakhrzad, A; Hassanipour, M; Hassanpour, S; Moezi, L; Shafaroodi, H | 1 |
Emamzadeh-Fard, S; Moazzami, K; Shabani, M | 1 |
KONICOV, M; MICHAELSON, SM; ORCUTT, JA; PRYTHERCH, JP | 1 |
Ashkenazi, S; Chrousos, GP; Ovadia, H; Weizman, A; Yuhas, Y | 1 |
Albertos, LM; Darias, V; Expósito-Orta, MA; Sánchez-Mateo, CC | 1 |
Arnold, T; Dost, R; Egerland, U; Grunwald, C; Höfgen, N; Hofmann, HJ; Lankau, HJ; Rundfeldt, C; Unverferth, K | 1 |
Bellido, L; Cruz, JJ; Martín, G | 1 |
Corre, KA; Rothstein, RJ | 1 |
Freeman, JJ; Kosh, JW; Powers, DL; Sowell, JW | 1 |
Attolini, L; Bruguerolle, B; Gantenbein, M | 1 |
Lasoń, W; Machelska, H; Przewłocka, B | 1 |
Chugh, Y; Saha, N; Sankaranarayanan, A; Sharma, PL | 1 |
Almond, HR; Carmosin, RJ; Carson, JR; Pitis, PM; Stables, JP; Swinyard, EA; Vaught, JL; White, HS; Wolf, HH | 1 |
Engel, J; Günther, R; Höfgen, N; Hofmann, HJ; Lankau, HJ; Liebscher, J; Menzer, M; Müller, B; Rolfs, A; Rostock, A; Unverferth, K | 1 |
Balsamini, C; Bedini, A; Di Fabio, R; Diamantini, G; Feriani, A; Reggiani, A; Spadoni, G; Tarzia, G; Tedesco, G; Tontini, A; Valigi, R | 1 |
Bräuner-Osborne, H; Conti, P; De Amici, M; De Micheli, C; De Sarro, G; Madsen, U; Stensbøl, TB | 1 |
Grigoriadis, DE; Heinrichs, SC; McCarthy, JR | 1 |
Drejer, J; Gouliaev, AH; Jensen, LH; Mathiesen, C; Moller, A; Nielsen, EO; Varming, T; Wätjen, F | 1 |
Farrant, RD; Langley, GJ; Mellor, JM; Mills, GA; Walker, V | 1 |
Bansinath, M; Ramabadran, K; Shukla, VK; Turndorf, H | 1 |
Zhang, S | 1 |
Baeyens, JM; Barrios, M; Del Pozo, E | 1 |
Cowlrick, IS; Paciorek, PM; Perkins, RS; Taylor, JC; Waterfall, JF; Wilkinson, GF | 1 |
Purkiss, P; Wajner, M; Wannmacher, CM | 1 |
Alzheimer, C; ten Bruggencate, G | 1 |
Filacchioni, G; Guaitani, A; Nacci, V; Porretta, GC; Stefancich, G | 1 |
Hester, JB; Rudzik, AD; Veldkamp, W | 1 |
1 review(s) available for pyrroles and Seizures
Article | Year |
---|---|
Recent advances with the CRF1 receptor: design of small molecule inhibitors, receptor subtypes and clinical indications.
Topics: Animals; Anxiety; Depression; Drug Design; Humans; Kinetics; Pyrimidines; Pyrroles; Receptors, Corticotropin-Releasing Hormone; Seizures; Substance-Related Disorders | 1999 |
38 other study(ies) available for pyrroles and Seizures
Article | Year |
---|---|
Convulsive Seizure Due to Hypomagnesemia Caused by Short-term Vonoprazan Intake.
Topics: Aged; Double-Blind Method; Female; Humans; Magnesium; Neoplasm Recurrence, Local; Proton Pump Inhibitors; Pyrroles; Seizures; Sulfonamides | 2022 |
Novel fluorinated pyrrolo[1,2-a]pyrazine-2,6-dione derivatives: synthesis and anticonvulsant evaluation in animal models of epilepsy.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Epilepsy; Halogenation; Hydrocarbons, Fluorinated; Male; Mice; Molecular Structure; Pentylenetetrazole; Pilocarpine; Pyrazines; Pyrroles; Rats; Rats, Sprague-Dawley; Seizures; Structure-Activity Relationship | 2014 |
Atorvastatin prevents development of kindling by modulating hippocampal levels of dopamine, glutamate, and GABA in mice.
Topics: Animals; Anticonvulsants; Atorvastatin; Dopamine; gamma-Aminobutyric Acid; Glutamic Acid; Heptanoic Acids; Hippocampus; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kindling, Neurologic; Male; Mice; Pyrroles; Seizures | 2015 |
NKCC1 up-regulation contributes to early post-traumatic seizures and increased post-traumatic seizure susceptibility.
Topics: Ammonia; Animals; Animals, Newborn; Bumetanide; Cell Count; Cerebral Cortex; Disease Models, Animal; Epilepsy, Post-Traumatic; Evoked Potentials; gamma-Aminobutyric Acid; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Phosphopyruvate Hydratase; Pyrazoles; Pyrroles; Seizures; Sodium Potassium Chloride Symporter Inhibitors; Solute Carrier Family 12, Member 2; Up-Regulation; Wakefulness | 2017 |
Statin inhibits kainic acid-induced seizure and associated inflammation and hippocampal cell death.
Topics: Animals; Atorvastatin; Cell Death; Disease Models, Animal; Dose-Response Relationship, Drug; Ectodysplasins; Heptanoic Acids; Hippocampus; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Situ Nick-End Labeling; Inflammation; Interleukin-1beta; Kainic Acid; Male; Nitric Oxide Synthase Type II; Pyrroles; Rats; Rats, Sprague-Dawley; Seizures; Tumor Necrosis Factor-alpha | 2008 |
Brain magnetic resonance imaging changes after sorafenib and sunitinib chemotherapy in patients with advanced renal cell and breast carcinoma.
Topics: Aged; Antineoplastic Agents; Benzenesulfonates; Brain; Brain Edema; Brain Neoplasms; Breast Neoplasms; Carcinoma, Renal Cell; Female; Humans; Indoles; Kidney Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Niacinamide; Phenylurea Compounds; Prospective Studies; Pyridines; Pyrroles; Seizures; Sorafenib; Sunitinib | 2009 |
Atorvastatin prevents hippocampal cell death due to quinolinic acid-induced seizures in mice by increasing Akt phosphorylation and glutamate uptake.
Topics: Analysis of Variance; Animals; Atorvastatin; Cell Death; Complex Mixtures; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Heptanoic Acids; Hippocampus; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Male; Mice; Oncogene Protein v-akt; Phosphorylation; Pyrroles; Quinolinic Acid; Seizures; Tetrazolium Salts; Thiazoles; Tritium | 2009 |
The effects of atorvastatin on memory deficit and seizure susceptibility in pentylentetrazole-kindled rats.
Topics: Analysis of Variance; Animals; Anticholesteremic Agents; Atorvastatin; Avoidance Learning; Disease Susceptibility; Electroencephalography; Heptanoic Acids; Kindling, Neurologic; Male; Memory Disorders; Pentylenetetrazole; Pyrroles; Rats; Rats, Wistar; Reaction Time; Seizures | 2010 |
Matrix metalloproteinase-9 may be a potential therapeutic target in epilepsy.
Topics: Animals; Anti-Bacterial Agents; Atorvastatin; Epilepsy; Gene Expression Regulation, Enzymologic; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Matrix Metalloproteinase 9; Mice; Minocycline; Models, Biological; Neurons; Pyrroles; Rats; Seizures; Treatment Outcome | 2011 |
Atorvastatin treatment during epileptogenesis in a rat model for temporal lobe epilepsy.
Topics: Animals; Anticonvulsants; Atorvastatin; Blood-Brain Barrier; Brain; Disease Models, Animal; Electroencephalography; Epilepsy, Temporal Lobe; Heptanoic Acids; Male; Pyrroles; Rats; Rats, Sprague-Dawley; Seizures; Triglycerides | 2011 |
Differential effects of atorvastatin treatment and withdrawal on pentylenetetrazol-induced seizures.
Topics: Animals; Anticonvulsants; Atorvastatin; Blood-Brain Barrier; Cerebral Cortex; Cholesterol; Convulsants; Electroencephalography; Heptanoic Acids; Male; Pentylenetetrazole; Pyrroles; Rats; Rats, Wistar; Seizures; Simvastatin | 2011 |
The interactions of atorvastatin and fluvastatin with carbamazepine, phenytoin and valproate in the mouse maximal electroshock seizure model.
Topics: Animals; Anticonvulsants; Atorvastatin; Brain; Carbamazepine; Disease Models, Animal; Drug Interactions; Electroshock; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Indoles; Male; Memory; Mice; Motor Activity; Phenytoin; Pyrroles; Seizures; Valproic Acid | 2012 |
Chronic administration of atorvastatin induced anti-convulsant effects in mice: the role of nitric oxide.
Topics: Analysis of Variance; Animals; Anticonvulsants; Atorvastatin; Convulsants; Disease Models, Animal; Drug Administration Routes; Drug Administration Schedule; Drug Interactions; Enzyme Inhibitors; Guanidines; Heptanoic Acids; Male; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pentylenetetrazole; Pyrroles; Seizures; Time Factors | 2012 |
Anticonvulsive effect of atorvastatin on pentylenetetrazole-induced seizures in mice: the role of nitric oxide pathway.
Topics: Animals; Anticonvulsants; Arginine; Atorvastatin; Heptanoic Acids; Male; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pentylenetetrazole; Pyrroles; Seizures; Signal Transduction | 2013 |
SOME NEW COMPOUNDS EXHIBITING SELECTIVE CNS-DEPRESSANT ACTIVITIES. I. PRELIMINARY OBSERVATIONS.
Topics: Animals; Azo Compounds; Benzimidazoles; Cats; Central Nervous System; Central Nervous System Depressants; Cricetinae; Dogs; Indoles; Lagomorpha; Mephenesin; Mice; Muscle Relaxants, Central; Phenylacetates; Pyrroles; Quinolines; Rabbits; Rats; Research; Seizures; Strychnine; Toxicology | 1964 |
Involvement of the neuropeptide corticotropin-releasing hormone in an animal model of Shigella-related seizures.
Topics: Animals; Corticotropin-Releasing Hormone; Disease Models, Animal; Male; Mice; Mice, Inbred ICR; Pentylenetetrazole; Pyrimidines; Pyrroles; Seizures; Shigella; Time Factors | 2004 |
Behavioural effects of thieno and pyrazolo [2,1] benzothiazepine derivatives in mice.
Topics: 5-Hydroxytryptophan; Animals; Anti-Anxiety Agents; Anticonvulsants; Antidepressive Agents; Apomorphine; Behavior, Animal; Central Nervous System Stimulants; Dextroamphetamine; Dopamine Agonists; Exploratory Behavior; Female; Hyperkinesis; Hypothermia; Male; Mice; Muscle Relaxants, Central; Pyrroles; Seizures; Stereotyped Behavior; Thiazepines | 2004 |
Synthesis, pharmacology, and structure-activity relationships of novel imidazolones and pyrrolones as modulators of GABAA receptors.
Topics: Administration, Oral; Animals; Anti-Anxiety Agents; Anticonvulsants; Binding Sites; Brain; GABA Antagonists; GABA-A Receptor Agonists; Imidazoles; Male; Mice; Models, Molecular; Morpholines; Pentylenetetrazole; Piperidines; Pyrroles; Quantitative Structure-Activity Relationship; Radioligand Assay; Rats; Rats, Wistar; Rotarod Performance Test; Seizures | 2006 |
Reversible posterior leukoencephalopathy syndrome induced by sunitinib.
Topics: Aged; Antineoplastic Agents; Bone Neoplasms; Brain; Brain Diseases; Carcinoma, Renal Cell; Female; Humans; Indoles; Kidney Neoplasms; Magnetic Resonance Imaging; Neoplasm Metastasis; Pyrroles; Seizures; Sunitinib; Syndrome; Treatment Outcome | 2007 |
Anaphylactic reaction to zomepirac.
Topics: Analgesics; Anaphylaxis; Anti-Inflammatory Agents; Blood Pressure; Epinephrine; Female; Humans; Hypersensitivity, Immediate; Middle Aged; Pruritus; Pyrroles; Rhinitis, Allergic, Seasonal; Seizures; Tolmetin | 1982 |
Anticonvulsant properties of selected pyrrolo[2,3-d]pyrimidine-2,4-diones and intermediates.
Topics: Animals; Anticonvulsants; Electroshock; Male; Mice; Pentylenetetrazole; Phenytoin; Pyrimidinones; Pyrroles; Seizures; Solubility; Structure-Activity Relationship; Trimethadione | 1980 |
Effect of four potassium channel agonists on bupivacaine-induced toxicity in mice.
Topics: Animals; Benzopyrans; Bupivacaine; Cromakalim; Diazoxide; Dose-Response Relationship, Drug; Guanidines; Male; Mice; Mice, Inbred Strains; Niacinamide; Nicorandil; Pinacidil; Potassium Channels; Pyrroles; Seizures | 1995 |
Kappa opioid receptor agonists inhibit the pilocarpine-induced seizures and toxicity in the mouse.
Topics: Analgesics; Animals; Benzeneacetamides; Brain; Injections, Intraperitoneal; Mice; Naltrexone; Pilocarpine; Pyrroles; Pyrrolidines; Receptors, Opioid, kappa; Seizures; Thiophenes | 1994 |
BRL 38227--a potassium channel opener, antagonizes digoxin-induced convulsions.
Topics: 4-Aminopyridine; Animals; Benzopyrans; Brain; Cromakalim; Digoxin; Dose-Response Relationship, Drug; Female; Injections, Intraventricular; Male; Potassium Channels; Pyrroles; Rats; Rats, Wistar; Seizures | 1993 |
Aroyl(aminoacyl)pyrroles, a new class of anticonvulsant agents.
Topics: Anesthesia; Animals; Anticonvulsants; Bicuculline; Calcium; Cerebellum; Electroshock; Mice; Models, Molecular; Molecular Structure; Pentylenetetrazole; Piperidines; Potassium; Pyrroles; Rats; Seizures; Structure-Activity Relationship; Veratridine | 1997 |
Synthesis, anticonvulsant activity, and structure-activity relationships of sodium channel blocking 3-aminopyrroles.
Topics: Animals; Anticonvulsants; Dose-Response Relationship, Drug; Electroshock; Indicators and Reagents; Male; Mice; Models, Molecular; Molecular Structure; Motor Activity; Neurotoxins; Pentylenetetrazole; Pyrroles; Rats; Rats, Sprague-Dawley; Seizures; Sodium Channel Blockers; Structure-Activity Relationship | 1998 |
(E)-3-(2-(N-phenylcarbamoyl)vinyl)pyrrole-2-carboxylic acid derivatives. A novel class of glycine site antagonists.
Topics: Acrylamides; Animals; Anticonvulsants; Cerebral Cortex; Glycine Agents; Indoles; Mice; Models, Molecular; N-Methylaspartate; Pyrroles; Rats; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate; Seizures; Structure-Activity Relationship; Synapses | 1998 |
Synthesis and pharmacology of a new AMPA-kainate receptor agonist with potent convulsant activity.
Topics: Animals; Convulsants; Excitatory Amino Acid Agonists; Isoxazoles; Mice; Pyrroles; Receptors, AMPA; Receptors, Kainic Acid; Seizures; Stereoisomerism; Structure-Activity Relationship | 1998 |
SPD 502: a water-soluble and in vivo long-lasting AMPA antagonist with neuroprotective activity.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Binding Sites; Binding, Competitive; Cell Membrane; Cells, Cultured; Cerebral Cortex; Electroshock; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid; Glycine; Isoquinolines; Kainic Acid; Kinetics; Male; Membrane Potentials; Mice; Mice, Inbred Strains; Molecular Structure; Neurons; Neuroprotective Agents; Patch-Clamp Techniques; Pipecolic Acids; Pyrroles; Quinoxalines; Rats; Rats, Wistar; Receptors, AMPA; Seizures; Stereoisomerism; Tetrahydroisoquinolines | 1999 |
Pyridoxal phosphate de-activation by pyrroline-5-carboxylic acid. Increased risk of vitamin B6 deficiency and seizures in hyperprolinemia type II.
Topics: Aldehydes; Avitaminosis; Chromatography, High Pressure Liquid; Humans; Ketones; Magnetic Resonance Spectroscopy; Mass Spectrometry; Proline; Pyridoxal Phosphate; Pyridoxine; Pyrroles; Seizures | 2001 |
Intracerebroventricular administration of kappa-agonists induces convulsions in mice.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Baclofen; Benzeneacetamides; Benzomorphans; Cerebral Ventricles; Convulsants; Dizocilpine Maleate; Injections, Intraventricular; Ketamine; Mice; Mice, Inbred Strains; Muscimol; Naloxone; Narcotic Antagonists; Narcotics; Pyrroles; Pyrrolidines; Receptors, Opioid; Receptors, Opioid, kappa; Seizures; Stereoisomerism; Thiophenes | 1991 |
[Species differences in subacute toxicity of pyrrole aldehyde N4-(4-methoxyphenyl) semicarbazone].
Topics: Animals; Blood Chemical Analysis; Dogs; Female; Male; Pyrroles; Rats; Rats, Inbred Strains; Seizures; Semicarbazones; Species Specificity | 1990 |
Effects of potassium channel openers on pentylenetetrazole-induced seizures in mice.
Topics: 4-Aminopyridine; Animals; Benzopyrans; Cromakalim; Drug Antagonism; Female; Guanidines; Mice; Pentylenetetrazole; Pinacidil; Potassium Channels; Pyrroles; Seizures | 1990 |
Evaluation of the bronchodilator properties of Ro 31-6930, a novel potassium channel opener, in the guinea-pig.
Topics: Albuterol; Anesthesia; Animals; Benzopyrans; Bronchodilator Agents; Cromakalim; Decerebrate State; Drug Interactions; Guinea Pigs; Histamine Antagonists; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth; Potassium Channels; Pyridines; Pyrroles; Seizures; Theophylline; Vagotomy | 1990 |
High urinary excretion of N-(pyrrole-2-carboxyl) glycine in type II hyperprolinemia.
Topics: Amino Acid Metabolism, Inborn Errors; Consanguinity; Electroencephalography; Glycine; Growth Disorders; Humans; Infant; Male; Proline; Pyrroles; Recurrence; Seizures | 1990 |
Actions of BRL 34915 (Cromakalim) upon convulsive discharges in guinea pig hippocampal slices.
Topics: Animals; Antihypertensive Agents; Benzopyrans; Calcium; Cromakalim; Electric Stimulation; Guinea Pigs; Hippocampus; In Vitro Techniques; Magnesium; Neurons; Potassium; Pyrroles; Seizures | 1988 |
[Research on compounds with psychotropic activity. II. Synthesis of 5-phenylpyrrolo-(2,1-d)-benzothiazepin-6,6-dioxide and 1,2,3,3a,4,5-hexahydro-5-phenylpyrrolo-(2,1-d) (1,5)-benzo-thiazepin-1,4-dione-6,6-dioxide derivatives and their pharmacological pro
Topics: Animals; Benzazepines; Disease Models, Animal; Male; Mice; Pyrroles; Seizures; Thiazepines; Tranquilizing Agents | 1973 |
Pyrrolo[3,2,1-jk][1,4]benzodiazepines and pyrrolo[1,2,3-ef][1,5]benzodiazepines which have central nervous system activity.
Topics: Animals; Behavior, Animal; Benzazepines; Central Nervous System; Chemical Phenomena; Chemistry; Diazepam; Male; Mice; Muscle Contraction; Nicotine; Pyrroles; Reflex; Seizures | 1970 |